Client MNRs and Landing Pages

Since 2004, brands have counted on Cision’s MultiVu to create and distribute their important news and marketing content to the world.

Let's talk

Search our recent client collaborations below:

Advanced Search
June 04, 2018

Dove Men+Care Champions Paternity Leave Fo...

Dove Men+Care Champions Paternity Leave For All Dads This Father’s Day ...
Read more
June 04, 2018

First Alert Marks Anniversary With ‘60 Yea...

First Alert Marks Anniversary With ‘60 Years Of Thank Yous’ Sweepstakes ...
Read more
June 04, 2018

It’s Hard to Have Honest Conversations Abo...

It’s Hard to Have Honest Conversations About Money. La...
Read more
June 04, 2018

New Downy Nature Blends Helps Extend the L...

New Downy Nature Blends Helps Extend the Life of Clothes With the Power of Plants ...
Read more
June 04, 2018

USA Swimming Foundation Sets GUINNESS WORL...

USA Swimming Foundation Sets GUINNESS WORLD RECORDS® for Largest Kickboard to Kic...
Read more
June 03, 2018

Erdafitinib Phase 2 Study Results Show Pro...

...
Read more
June 01, 2018

Black Women are 40% More Likely to Die fr...

Black Women are 40% More Likely to Die from Breast Cancer than White Women; Susan G. Komen&...
Read more
June 01, 2018

Maggiano’s Celebrates 15 Years Of Partners...

Maggiano’s Celebrates 15 Years Of Partnership With Make-A-Wish® ...
Read more
June 01, 2018

U by Kotex® addresses need for period prod...

U by Kotex® addresses need for period products, serves as founding sponsor of All...
Read more
June 01, 2018

Practice Makes Perfect: Studying a Little ...

Practice Makes Perfect: Studying a Little Each Day is Key to Improving Academic Achievement...
Read more
May 31, 2018

New Cigna Study Reveals Loneliness at Epid...

New Cigna Study Reveals Loneliness at Epidemic Levels in America Research Puts Spotlight on the Impact of Loneliness in the U.S. and Potential Root Causes BLOOMFIELD, Conn. – May 1...
Read more
May 31, 2018

UCB Announces the Approval of CIMZIA® (cer...

UCB Announces the Approval of CIMZIA® (certolizumab pegol) for Moderate-to-Severe...
Read more
Get Started!